# Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo

**Authors:** Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagozdzon, Pawel Wisniewski

PMC · DOI: 10.1007/s00262-024-03727-0 · Cancer Immunology, Immunotherapy : CII · 2024-07-05

## Full-text entities

- **Diseases:** Cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11226685/full.md

---
Source: https://tomesphere.com/paper/PMC11226685